Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.
MarketBeat on MSN
AI Pharma: 2 Paths to AI-Powered Drug Investment
The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...
Join us for a webinar on how advances in target-based drug discovery are reshaping therapeutic design. We’ll explore ...
News-Medical.Net on MSN
OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate
OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round.
Headlamp Health has launched Lumos AI®, a new decision-support platform designed to bring greater precision to neuroscience ...
Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...
Cold Spring Harbor Laboratory's advanced mass spectrometry method enhances sensitivity, facilitating better drug target discovery and biological research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback